Childhood Neurotherapeutics

Since being approved for funding in 2006, the Childhood Neurotherapeutics Center of Economic Excellence (CoEE) has produced basic discoveries, generated therapeutic trials, developed intellectual property, and created spin-off companies and relationships with pharmaceutical firms. The CoEE has succeeded in positioning South Carolina as a future leader in pharmaceutical and biotechnological advances in the dynamic field of childhood neurotherapeutics.

This CoEE is developing new approaches to diagnosing and treating childhood neurological and brain disorders that cannot currently be cured. If successful, these approaches could potentially be used to treat adult neurological and brain disorders such as multiple sclerosis, Parkinson’s and Alzheimer’s disease.

Learn More